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Objective: The objective of this study was to assess outcome differences in aortic valve replacement
based on gender.
Methods: A study from a ten-year hospitalization cohort with prospective data collection was conducted.
Included in the study were patients undergoing aortic valve replacement surgery between March 1997
and July 2003 (N¼ 406). There were 223 males and 183 females included in the study. The study
examined 41 potential confounding risk factors and 16 outcome variables.
Results: Univariate analysis on potential confounding risk factors revealed a signiﬁcant difference
between males and females on 12 factors. Co-morbid disease, hypertension, current vascular disease,
aortic insufﬁciency, body surface area, blood added on pump, and annulus size signiﬁcantly correlated
with age. The correlation resulted in ﬁve confounding risk factors: age, tobacco history, obesity, left
ventricular hypertrophy, and creatinine level. Logistic regression analysis found that after controlling for
age, tobacco history, obesity, left ventricular hypertrophy, and creatinine level, there is no difference
between males and females on outcomes following aortic valve replacement. Additionally, choice of
vascular prosthesis had no impact on post-operative outcomes.
Conclusion: After controlling for confounding variables, similar outcomes were observed for males and
females undergoing aortic valve replacement.
 2009 Surgical Associates Ltd. Published by Elsevier Ltd. All rights reserved.1. Introduction
Women undergoing coronary artery bypass grafting (CABG) are
reported to be at increased risk for post-operative morbidity and
mortality.1,2 Aortic valve replacement (AVR) can be performed
either in isolation or in conjunction with CABG. In aortic valve
surgeries combinedwith CABG, female gender has been found to be
an independent risk factor for morbidity and mortality.1–4 This
increased risk inwomen is partially related to gender differences in
preoperative risk proﬁles.5,6 Men and women with similar degrees
of aortic stenosis and clinical status without coronary disease have
different adaptations. Women more frequently have a greater
degree of ventricular hypertrophy, smaller end systolic and endA, Body surface area; CABG,
ive pulmonary disease; IABP,
LVH, Left ventricular hyper-
ork Heart Association.
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ciates Ltd. Published by Elsevier Ltdiastolic chamber size, higher relative wall thickness, greater frac-
tional shortening and higher ejection fractions.7 In the case of aortic
regurgitation, women are more likely to have aortic valve surgery
for class III and IV symptoms and men for severe left ventricular
dysfunction.3,8 Previous literature has been inconsistent regarding
the effect of gender on outcomes following isolated aortic valve
surgery. Some authors have determined that the operative
morbidity and mortality were similar in men and women for iso-
lated AVR.8–10 However, other authors have found that female
gender is associated with a 2.5 fold increase risk in post-operative
cardiac morbidity and mortality after AVR surgery.5 The present
study examined gender as a risk factor for morbidity and mortality
after isolated AVR.
2. Methods
A ten-year hospitalization cohort (N¼ 11,398) with prospective
data collection was conducted after receiving institutional review
board approval. Nurses, physicians, and perfusionists collected data
on 225 variables during admission. Data were grouped into
demographics, medical history, postoperative, perfusion, and
procedure sections. Using a series of cross-checking questions, twod. All rights reserved.
Table 1
Deﬁnitions of potential confounding risk factors.
Variables Deﬁnition of variables
Race Caucasian, other
Signiﬁcant associative disorder no, yes (dialysis, gout, ch steroids, phsch hx, CA,
chr aﬁb, int aﬁb, VT/VF, prior mediastinal
radiation)
Other systemic diseases no, yes (syphilis, lupus, marfan’s, rheum heart
disease, ETOH, rheum arthritis, drug abuse,
HIVþ, AIDS)
COPD no, yes
Diabetes no, yes (diet, oral meds, insulin dependent)
Hypertension no, yes (diastolic blood pressure> 90 mmHg)
Tobacco history no, yes
Neurological history no, yes (seizures, encephalopathy or dementia,
neuromuscular, tumor, intracranial
hemorrhage, aneurysm, other)
Current vascular disease No, yes (carotid, vertebral, innominate,
subclavian, thoracic aorta, abdominal aorta,
visceral/renal, upper extremity, lower
extremity)
Obesity no, yes (>1.5 times ideal weight)
Cor sinus CP site no, yes
Urgency of Procedure elective, non-elective (urgent, emergent,
desperate)
NYHA Functional Class Class I, Class II, Class III, Class IV
Cardiac pathology – aortic
stenosis
no, yes
Cardiac pathology – aortic
insufﬁciency
no, yes
Cardiac pathology – mitral
stenosis
no, yes
Cardiac pathology mitral
insufﬁciency
no, yes
Cardiac pathology – aortic
aneurysm
no, yes
Aortic disease no, yes (atherosclerotic, dilated, dissection,
calciﬁed, severe, thin, soft, aneurysm, thick wall,
old graft, aneurysmal origin of vein graft)
Transesophageal color ﬂow no, yes
Abnormal LVH normal, abnormal (mild, moderate, or severe)
LV ejection fraction no, yes (39 or less)
Procedure – prosthetic no, yes
Procedure – conduit no, yes
Procedure – ross mi/root no, yes
Etiology - atheroscl no, yes
Echo result Satisfactory, unsatisfactory
Age Years
Creatinine level mg%
Pump time Minutes
Cross-clamp time Minutes
Blood added on pump ml
Annulus size mm
Body surface area m2
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tency. To further ensure accuracy and consistency, a physician
audited at random 10% of patient forms. Data were then entered
into an interactive multi-institutional database (Patient Analysis
and Tracking System, Axis Clinical Systems, Portland, OR).
Included in the study were patients aged 18 and older under-
going AVR surgery between March 1997 and July 2003 (N¼ 406).
Patients who underwent any surgery other than AVR or in combi-
nation with AVR were excluded. There were 223 males and 183
females included in the study.
The study examined 41 potential confounding risk factors. The
dichotomous potential confounding risk factors included race,
tobacco history, diabetes, hypertension and obesity. Additional risk
factors included other systemic disorders, signiﬁcant associative
disorders, chronic obstructive pulmonary disorder (COPD) and
neurological history. Current vascular disease, previous cardiac
surgery, cor sinus CP site, urgent surgical procedure, New York
Heart Association (NYHA) functional class were also considered as
risk factors. Cardiac pathology risk factors included aortic stenosis,
aortic insufﬁciency, mitral valve stenosis, mitral insufﬁciency and
aortic aneurysm. Aortic disease, transesophageal color ﬂow, left
ventricular hypertrophy (LVH), left ventricular ejection fraction
estimate, and echo result were additional risk factors. Procedural
risk factors included a prosthetic and ross mix/root. Etiological risk
factors were: atherosclerosis, congential, rheumatic, degenerative,
Marfan syndrome, infection, and trauma. The continuous potential
confounding risk factors included age, body surface area (BSA),
creatinine level, pump time, cross-clamp time, volume of blood
added on pump, and annulus size. Table 1 lists the deﬁnitions for
the potential confounding risk factors.
The 16 outcome variables were hours on ventilator, intensive care
unit (ICU) length of stay, total length of hospitalization (LOH),
arrhythmias requiring treatment, positive cultures, renal complica-
tions, sternal wound complications, neurologic complications,
pulmonarycomplications, gastrointestinal complications, lowcardiac
output, intra-aortic balloon pump (IABP), return to ICU, pulmonary
hypertension, intra-operative complications, and mortality. Table 2
lists the deﬁnitions for each of the outcome variables.
To generate the unadjusted risks of each potential confounding
risk factor, Chi-square and t-tests comparing males and females with
each of the 41 variables were performed. Correlation coefﬁcients
were computed among the signiﬁcant confounding risk factors. Chi-
square and t-tests were conducted comparing males and females
with each of the 16 outcomes. Logistic regression analysis was then
used to investigate the adjusted risk between cases and controlswith
each of the signiﬁcant outcome variables, while controlling for the
signiﬁcant risk factors. SPSS (SPSS Corporation, Chicago, Illinois)
statistical software was used to perform the analyses.
3. Results
Univariate analysis on potential confounding risk factors
revealed a signiﬁcant difference between males and females on 12
factors (Table 3). Males had signiﬁcantly higher creatinine level
(p¼ 0.020), larger BSA (p< 0.001), and larger annulus size
(p< 0.001). Males also had more tobacco history (p¼ 0.003), aortic
insufﬁciency (p¼ 0.013), and LVH (p¼ 0.026). Females were
signiﬁcantly older (p< 0.001) and required more blood added on
pump (p< 0.001). Females also had more signiﬁcant associative
disorders (p¼ 0.008), hypertension (p¼ 0.007), current vascular
disease (p¼ 0.017), and obesity (p< 0.001).
Correlation coefﬁcients were calculated for the 12 signiﬁcant
confounding risk factors. Seven of the 12 risk factors signiﬁcantly
correlated with age. These factors include associative disorder,
hypertension, current vascular disease, aortic insufﬁciency, BSA,blood added on pump, and annulus size. The correlation resulted in
ﬁve confounding risk factors: age, tobacco history, obesity, LVH, and
creatinine level.
There was a signiﬁcant difference between males and females
following AVR on one outcome variable: greater number of females
(65%) experienced low cardiac output following AVR (p¼ 0.016).
There was no signiﬁcant difference between males and females for
the remaining 15 outcome variables.
Logistic regression analysis showed that after controlling for
age, tobacco history, obesity, LVH, and creatinine level, there is no
difference between males and females on low cardiac output (OR
1.5, CI 0.95–2.5, p¼ 0.077). No signiﬁcant difference in outcomes
was found between males and females following AVR.4. Discussion
Previously CABG has been examined for gender related
outcomes, and unadjusted mortality andmorbidity rates have been
Table 4
Reported gender related mortality after isolated AVR.
Study Number of
patients
Risk unadjusted
mortality and
morbidity
Risk adjusted
mortality and
morbidity
Scott et al., 19859 Total 1479 Overall mortality
was 7%
No gender related
difference in
mortalityM 1080 No gender related
difference
F 399
Lytle et al., 198910 Total 1689 Overall mortality
3.4%
No gender related
difference in
mortalityM 1230 Male 2.9%
F 459 Female 4.6%
Duncan et al., 20065 Total 2212 Overall mortality
2.3%
2.5 fold increase in
cardiac morbidity
and mortalityM 1430 Male 1.6%
F 782 Female 3.5%
P-value< 0.05
Hamed et al. (present
investigation)
Total 406 Overall mortality
3.4%
No gender related
difference in
mortalityM 223
F 183
Table 3
Univariate analysis of 12 signiﬁcant confounding risk factors.
Control Males Females p-value
Signiﬁcant associate disorders 57/223 (26%) 69/182 (38%) 0.008
Hypertension 101/223 (45%) 107/182 (59%) 0.007
Tobacco history 89/187 (48%) 54/167 (32%) 0.003
Current vascular disease 8/223 (4%) 17/182 (9%) 0.017
Obesity 25/222 (11%) 49/181 (27%) <0001
Cardiac pathology – aortic insufﬁciency 111/222 (50%) 69/183 (38%) 0.013
LVH 208/220 (95%) 160/181 (88%) 0.026
Mean SD Mean SD p-value
Age 60.5 14.4 67.1 14.2 0.020
Body surface area 2.1 0.2 1.7 0.2 <0.001
Creatinine level 1.3 0.8 1.1 0.9 <0.001
Blood added on pump 88.0 385 264.3 449 <0.001
Annulus size 24.7 4.6 21.5 2.8 <0.001
Table 2
Deﬁnition of outcome variables.
Hospital outcomes Deﬁnition of variables
Arrhythmias requiring
treatment
no, yes (PVC/VT, AF/FL, VF, Req deﬁb,
Cardioverted, Pacer Req/Brady, A-V Dis)
Positive cultures No, yes (blood, urine, venous lines, arterial)
Renal complications no, yes (mild: double preop creatinine;
moderate: Cr> 4.0; severe: requiring dialysis)
Sternal wound infections no, yes (any sternal wound infection including
dehisence or ones requiring surgery)
Neurological complications no, yes (any neurological complication
including mental status change, CVA, peripheral
nerve, seizure, TIA). Type I stroke – mild
hemispheric, severe hemispheric, severe other
(brain stem). Type II stroke –mildmental status,
severe mental status, confusion only.
Pulmonary complications no, yes (any pulmonary complication with the
exception of mild atelectasis)
Gastrointestinal complications no, yes (any including severe GI bleeding,
perforated ulcer, cholecystitis, hepatitis,
pancreatitis, bowel obstruction, ileus, ischemic
bowel)
Low output No, yes (mild – dopamine</¼ 2mcg/kg/min,
moderate – press x1, severe – press x2 or more,
IABP & press, IABP & 2 press)
IABP no, yes (before cath, before surg, at surg, postop
in ICU, attempted/failed)
Return to ICU no, yes
Pulmonary hypertension no, yes (PA 60 mmHg)
Intra-operative complications No, yes (dissection, hemorrhage, pre bypass
arrhythmia, cardiac laceration, cardiac dilation,
air embolism, MI, Ao tear, post bypass arrest,
valve trauma, post bypass arrhythmia, IMA/
radial/other harvest – not satisfactory, redo
valve prosthesis, protamine reaction, cut patient
CABG, additional incision required)
Mortality no, yes
OR ventilator time hours on ventilator
ICU length of stay time in hours of stay in the intensive care unit
Total hospital length of stay duration in days from operation to discharge
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rates were determined before realizing that women undergoing
CABG have different characteristics and risk proﬁles than men.6
Several other investigators reported risk adjusted mortality and
morbidity and found few, if any, differences in outcomes between
males and females undergoing CABG.1,2,4
Outcomes after aortic valve replacement have been reported to
be worse in women than men; this was confounded by some
authors focusing on patients with advanced age8 or including other
procedures.3,10,12–17 There are few reports that focused on gender
related outcome after isolated AVR (Table 4).5,9,10
Similar to previously published studies,5,10,18 we determined
that females undergoing isolated AVR have different risk proﬁles
than men. Women were more likely to be older and obese, with
smaller BSA and hypertension and suffer from other vascular
diseases. Additionally, in our study, females required more blood
transfusions than males. Older age and advanced stage of disease
were found to be associated with increased mortality after AVR.10,18
Small body size in general has been proposed as a risk factor for
adverse outcome in females undergoing AVR because of receiving
smaller prosthetic valves,16,18 and more frequent aortic annular
enlargement procedures.18 Also females undergoing AVR received
more blood transfusions than males indicating greater technical
difﬁculty associated with smaller anatomy.
With these differences in risk proﬁles, outcomes should be
reported only after controlling for potential confounding factors.
There are several ways to do so; we used logistic regression to
control for potential confounding factors which were determinedby univariate analysis. Despite these differences in risk proﬁles, we
determined that after controlling for all potential confounding risk
factors there are no differences in morbidity andmortality between
men and women following AVR surgery. Our ﬁndings supported
previously published literature.9,10 Duncan et al.5 reported a 2.5
fold increase in cardiac morbidity and in hospital mortality in
females after AVR as compared to males. They used propensity
matching to control for confounding risk factors. As a result, they
had to exclude a large number of female patients and use only those
who match with their counterpart males.
There are several limitations to our study: our sample size is
relatively small compared to previous reports that addressed the
same issue which signiﬁcantly affects the power of the study. All
surgeries were performed by one surgical group that operated in
numerous local hospitals. The multi-institutional nature of the
database may result in some inaccuracy of the data that would be
reﬂected in the ﬁnal results.
In summary, the risk proﬁle of female patients undergoing AVR
is signiﬁcantly different from that of men. In our study, female
gender was not an independent risk factor for increased short term
morbidity and mortality after isolated aortic valve replacement.
Post-operative low output, the only outcome variable with
a signiﬁcant gender difference, was not signiﬁcant when control-
ling for age, tobacco history, obesity, LVH, and creatinine level. This
is in agreement with previous reports by other researchers who
O. Hamed et al. / International Journal of Surgery 7 (2009) 214–217 217have also found gender not to be an independent risk factor in
isolated AVR.19,20
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